Skip to main content
. 2018 Apr 27;12:997–1008. doi: 10.2147/DDDT.S151029

Figure 3.

Figure 3

Rate of inhibition of breast cancer cells treated with various concentrations of 4-amino-2-trifluoromethyl-phenyl retinate (ATPR) or all-trans retinoic acid (ATRA) for 24, 48, and 72 h (x¯±s, n = 3). MCF-7, MDA-MB-231, MDA-MB-435, and MDA-MB-453 cells.